Analysis Demonstrates Effectiveness of LY-CoV555 Antibody in Preventing Symptomatic COVID-19

NEXT STORY
Amarin Expands Cardiovascular Risk Reduction Patent Infringement Lawsuit to Include Health Care Insurance Provider
PREV STORY
Brown & Brown, Inc. Announces Quarterly Revenues of $642.1 Million, an Increase of 10.9%, and Diluted Net Income Per Share of $0.34
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

MediWound Reports Third Quarter 2017 Financial Results

NexoBrid® sales grow 74% year-to-date Raised gross proceeds of $25.2 million through public equity ...

author_avatar
NASDAQ Market News

Polyphor Hosting Key Opinion Leader Roundtable on Covid-19: The Need for Novel Therapies for Severe Infections and the Potential Role of Balixafortide, a Selective CXCR4 Antagonist

author_avatar
NASDAQ Market News

Intrexon, ZIOPHARM and Merck KGaA, Darmstadt, Germany Advancing Next-Generation Non-Viral CAR-T Platform Empowered by Membrane-Bound IL-15 Under RheoSwitch Therapeutic System® Control

GERMANTOWN, Md. and BOSTON, April 03, 2017 (GLOBE NEWSWIRE) -- Intrexon Corporation (NYSE:XON), a ...

author_avatar
NASDAQ Market News